| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09fe439401704e15fb3520fd3cf9f8d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ebdffe12052dfbf82097466606b9eba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_becf183d814f3f76eca0db3b58b4757d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17e6c778a71c468773a533a0b4dcd1e8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y101-01088 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-07 |
| filingDate |
2009-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60e700007575b232384d0f24894995df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e384a9d991c79ef44375d4cebeff59f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31da3854e7dc0d2d924f4d0355900b1f |
| publicationDate |
2010-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010072926-A1 |
| titleOfInvention |
Hmg-coa reductase derived peptide and cosmetic or pharmaceutical composition containing same |
| abstract |
The present invention relates to a peptide of general formula (I): R1-(AA)n-X1-Gly-Glu-Leu-SBr-X2-X3-(AA)P-R2, derived from human HMG-CoA reductase. The present invention also relates to a cosmetic or pharmaceutical composition comprising at least one peptide of general formula (I), in a physiologically suitable medium. The present invention also relates to the use of this novel peptide, as an active ingredient which activates human HMG-CoA reductase, in a cosmetic composition intended to reinforce the skin barrier function and to stimulate epidermal differentiation. The invention also relates to a cosmetic treatment method intended to prevent and/or combat external attacks and the manifestations of skin ageing. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2999186-A1 |
| priorityDate |
2008-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |